Pinnacle Holdings’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$75.8K Hold
400
0.02% 171
2026
Q1
$78.9K Hold
400
0.03% 177
2025
Q4
$73.5K Hold
400
0.02% 181
2025
Q3
$61.4K Hold
400
0.02% 186
2025
Q2
$55.9K Hold
400
0.02% 187
2025
Q1
$58.8K Hold
400
0.02% 185
2024
Q4
$52.4K Hold
400
0.02% 192
2024
Q3
$62.3K Hold
400
0.02% 184
2024
Q2
$62.4K Sell
400
-50
-11% -$7.52K 0.03% 188
2024
Q1
$61K Hold
450
0.02% 181
2023
Q4
$60.6K Hold
450
0.02% 184
2023
Q3
$60.9K Hold
450
0.03% 177
2023
Q2
$64.4K Buy
+450
New +$66.2K 0.03% 175
2023
Q1
Sell
-450
Closed -$61K 264
2022
Q4
$61K Hold
450
0.03% 172
2022
Q3
$49.4K Hold
450
0.02% 179
2022
Q2
$59.5K Hold
450
0.03% 179
2022
Q1
$59.7K Hold
450
0.02% 186
2021
Q4
$52.4K Hold
450
0.02% 204
2021
Q3
$54.1K Hold
450
0.02% 207
2021
Q2
$53.9K Hold
450
0.02% 169
2021
Q1
$44.7K Hold
450
0.02% 177
2020
Q4
$45K Hold
450
0.02% 177
2020
Q3
$49.3K Hold
450
0.03% 173
2020
Q2
$47.6K Hold
450
0.02% 165
2020
Q1
$40.2K Buy
450
+200
+80% +$18.8K 0.02% 165
2019
Q4
$24.9K Hold
250
0.01% 169
2019
Q3
$22.3K Hold
250
0.01% 176
2019
Q2
$20.6K Buy
+250
New +$19.6K 0.01% 174
2019
Q1
Sell
-250
Closed -$19K 197
2018
Q4
$19K Buy
+250
New +$19.5K 0.01% 181

Other funds holding AZN

Pinnacle Holdings's AZN Position: Q2 2026 in Review

Pinnacle Holdings held its AstraZeneca (AZN) position steady in Q2 2026 at 400 shares worth $75.8K. The position accounts for 0.02% of the portfolio, ranked #171.

Pinnacle Holdings first reported a position in AZN in Q4 2018 and has held it in 29 quarters since. The position peaked at $78.9K in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Pinnacle Holdings held 400 shares of AstraZeneca worth $75.8K as of Q2 2026.
  • Pinnacle Holdings left its AstraZeneca share count unchanged in Q2 2026.
  • AstraZeneca made up 0.02% of Pinnacle Holdings's portfolio in Q2 2026, its #171 holding.
  • Pinnacle Holdings first reported a position in AstraZeneca in Q4 2018 and has held it in 29 quarters since.
  • Pinnacle Holdings's AstraZeneca position peaked at $78.9K in Q1 2026.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Pinnacle Holdings's 13F filing for Q2 2026, filed 12 Aug 2026.